APA (7th ed.) Citation

W, C., S, X., H, H., W, D., L, Z., Y, L., . . . M, L. (2026). HBsAg loss in chronic hepatitis B patients with an HBsAg decline plateau can be enhanced by intermittent PEG-IFN treatment. Frontiers in cellular and infection microbiology, 16, 1778016. https://doi.org/10.3389/fcimb.2026.1778016

Chicago Style (17th ed.) Citation

W, Cao, et al. "HBsAg Loss in Chronic Hepatitis B Patients with an HBsAg Decline Plateau Can Be Enhanced by Intermittent PEG-IFN Treatment." Frontiers in Cellular and Infection Microbiology 16 (2026): 1778016. https://doi.org/10.3389/fcimb.2026.1778016.

MLA (9th ed.) Citation

W, Cao, et al. "HBsAg Loss in Chronic Hepatitis B Patients with an HBsAg Decline Plateau Can Be Enhanced by Intermittent PEG-IFN Treatment." Frontiers in Cellular and Infection Microbiology, vol. 16, 2026, p. 1778016, https://doi.org/10.3389/fcimb.2026.1778016.